272 related articles for article (PubMed ID: 15093254)
21. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
22. Responses of the immune system to injury.
Descotes J; Choquet-Kastylevsky G; Van Ganse E; Vial T
Toxicol Pathol; 2000; 28(3):479-81. PubMed ID: 10862568
[TBL] [Abstract][Full Text] [Related]
23. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
24. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers of immunotoxicity in man.
Descotes J; Nicolas B; Vial T; Nicolas JF
Biomarkers; 1996; 1(2):77-80. PubMed ID: 23888916
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistance.
Germolec DR
Toxicol Lett; 2004 Apr; 149(1-3):109-14. PubMed ID: 15093255
[TBL] [Abstract][Full Text] [Related]
27. Prospects for developmental immunotoxicity guidance and an update on ICH S8.
Hastings KL
J Immunotoxicol; 2005 Oct; 2(4):217-20. PubMed ID: 18958677
[TBL] [Abstract][Full Text] [Related]
28. [Animal models for assessment of GMO allergenicity: advantages and limitations].
Adel-Patient K; Wal JM
Eur Ann Allergy Clin Immunol; 2004 Mar; 36(3):88-91. PubMed ID: 15137477
[TBL] [Abstract][Full Text] [Related]
29. Safety assessment and dose selection for first-in-human clinical trials with immunomodulatory monoclonal antibodies.
Muller PY; Brennan FR
Clin Pharmacol Ther; 2009 Mar; 85(3):247-58. PubMed ID: 19177065
[TBL] [Abstract][Full Text] [Related]
30. Immunotoxicity: the risk is real.
Selgrade MK
Toxicol Sci; 2007 Dec; 100(2):328-32. PubMed ID: 17878151
[TBL] [Abstract][Full Text] [Related]
31. The immunosuppressive effect of methylmercury does not preclude development of autoimmunity in genetically susceptible mice.
Häggqvist B; Havarinasab S; Björn E; Hultman P
Toxicology; 2005 Mar; 208(1):149-64. PubMed ID: 15664442
[TBL] [Abstract][Full Text] [Related]
32. Are pesticides immunotoxic?
Botham PA
Adverse Drug React Acute Poisoning Rev; 1990; 9(2):91-101. PubMed ID: 2220474
[TBL] [Abstract][Full Text] [Related]
33. Immunotoxicity testing in nonhuman primates.
Grote-Wessels S; Frings W; Smith CA; Weinbauer GF
Methods Mol Biol; 2010; 598():341-59. PubMed ID: 19967524
[TBL] [Abstract][Full Text] [Related]
34. Immunotoxicology of immunomodulators.
Descotes J
Dev Biol Stand; 1992; 77():99-102. PubMed ID: 1426677
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of preclinical testing for allergic side effects.
Bala S; Weaver J; Hastings KL
Toxicology; 2005 Apr; 209(2):195-200. PubMed ID: 15767036
[TBL] [Abstract][Full Text] [Related]
36. Justification for routine screening of pharmaceutical products in immune function tests: a review of the recommendations of Putman et al. (2003).
Ryle PR
Fundam Clin Pharmacol; 2005 Jun; 19(3):317-22; discussion 329-30. PubMed ID: 15910654
[TBL] [Abstract][Full Text] [Related]
37. Popliteal lymph node assay: facts and perspectives.
Ravel G; Descotes J
J Appl Toxicol; 2005; 25(6):451-8. PubMed ID: 15986413
[TBL] [Abstract][Full Text] [Related]
38. Immunotoxicology: review of current status.
Luster MI; Germolec DR; Rosenthal GJ
Ann Allergy; 1990 May; 64(5):427-32. PubMed ID: 2186671
[TBL] [Abstract][Full Text] [Related]
39. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
40. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
